SEPARATION AGREEMENTSeparation Agreement • April 1st, 2019 • OncoCyte Corp • In vitro & in vivo diagnostic substances • California
Contract Type FiledApril 1st, 2019 Company Industry JurisdictionThis Separation Agreement (“Separation Agreement”) is entered into by and between Kristine Mecham (“Executive”) and OncoCyte Corporation. (the “Company”) and confirms the agreement that has been reached with Executive in connection with Executive’s separation from the Company.